+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
From
Marginal Zone Lymphoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Marginal Zone Lymphoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Glioblastoma Multiforme (GBM) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Bevacizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Bevacizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Filgrastim - Biosimilar Insight, 2022 - Product Thumbnail Image

Filgrastim - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
Trastuzumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Trastuzumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Follicular Lymphoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Follicular Lymphoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Osteosarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Osteosarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Cancer Anorexia - Epidemiology forecast- 2032 - Product Thumbnail Image

Cancer Anorexia - Epidemiology forecast- 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Acute Myeloid Leukemia (AML) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Multiple Myeloma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Multiple Myeloma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Intrahepatic Cholangiocarcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Intrahepatic Cholangiocarcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Locally Advanced Pancreatic Cancer - Pipeline Insight, 2021 - Product Thumbnail Image

Locally Advanced Pancreatic Cancer - Pipeline Insight, 2021

  • Drug Pipelines
  • September 2021
  • 60 Pages
  • Global
From
Treakisym - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Treakisym - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 50 Pages
  • Global
From
Blinatumomab - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Blinatumomab - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 50 Pages
  • Global
From
Aliqopa - Drug Insight and Market Forecast, 2030 - Product Thumbnail Image

Aliqopa - Drug Insight and Market Forecast, 2030

  • Report
  • February 2021
  • 50 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more